J&J Ditropan XL Patent Invalidated In Mylan Suit
This article was originally published in The Pink Sheet Daily
Executive Summary
Mylan win evens score before W.Va. District Court judge who had previously ruled J&J's Levaquin patents were valid and infringed.
You may also be interested in...
Mylan And J&J Cut A Deal For Generic Ditropan XL
Mylan could become the authorized generic for the 15 mg dose of the overactive bladder product.
Mylan And J&J Cut A Deal For Generic Ditropan XL
Mylan could become the authorized generic for the 15 mg dose of the overactive bladder product.
Mylan Loses Challenge To “Authorized” Generics In W.Va. Court
Federal judge says 180-day exclusivity period was not intended to prohibit competition from NDA holder.